Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001136261-15-000246
Filing Date
2015-08-06
Accepted
2015-08-06 16:20:04
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q body10q.htm 10-Q 534347
2 CEO 302 CERTIFICATE exh31-1.htm EX-31.1 5211
3 CFO 302 CERTIFICATE exh31-2.htm EX-31.2 4905
4 906 CERTIFICATE exh32-1.htm EX-32.1 3304
5 LOGO image1904.jpg GRAPHIC 6415
  Complete submission text file 0001136261-15-000246.txt   3592302

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ptx-20150630.xml EX-101.INS 698771
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptx-20150630.xsd EX-101.SCH 39711
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptx-20150630_cal.xml EX-101.CAL 74394
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptx-20150630_def.xml EX-101.DEF 67803
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptx-20150630_lab.xml EX-101.LAB 321294
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptx-20150630_pre.xml EX-101.PRE 224449
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

EIN.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14494 | Film No.: 151033390
SIC: 2834 Pharmaceutical Preparations